Last updated: February 24, 2026
What is the scope of patent HRP20200046?
Patent HRP20200046 is a Croatian patent protecting a pharmaceutical composition or method involving a specific active compound or combination. Based on publicly available data, the patent was filed to safeguard a drug candidate or therapeutic approach addressing a particular medical condition. The patent's scope covers formulations, manufacturing processes, and methods of use related to the active ingredient(s).
The patent claims to provide novel, inventive specific uses or formulations which differ substantively from prior art. It emphasizes a unique combination, form, or method intended to enhance efficacy, safety, stability, or delivery.
What are the key claims within HRP20200046?
The patent's claims structure closely follows standard pharmaceutical patent practice, focusing on:
- The active compound or composition, with precise chemical definitions.
- Specific formulations, including dosage forms, excipients, and stabilizers.
- Methods of manufacturing or synthesizing the compound.
- Methods of treatment or use in particular medical conditions.
Sample Claim Breakdown:
| Claim Type |
Content |
Details |
| Independent |
Composition or method of treatment |
Defines a pharmaceutical composition comprising a specified active ingredient in a certain dosage range. May specify a combination therapy with other agents. |
| Dependent |
Stabilizers, excipients, or formulations |
Claims specific excipients, encapsulation methods, or formulations that improve bioavailability or stability. |
| Method of use |
Treatment of a disease |
Claims methodological treatment involving administering the composition to patients with a particular disease indication. |
Exact claim language is not available publicly but generally follows these structures in pharmaceutical patents.
What does the patent landscape for this drug look like?
Geographic Coverage
Patent HRP20200046 is a Croatian national patent. Its territorial scope is limited to Croatia, unless extended via PCT applications or national phase filings in other jurisdictions.
Related Patents and Applications
The patent family likely includes:
- PCT application (WO publication) providing broader international protection.
- National filings in key markets (EU, US, others).
- Similar patents focused on the same or related compounds, filed by the same or competing entities.
Available data indicates the patent family may include subordinate patents claiming similar inventions with slight modifications or specific regional variations.
Patent Landscape Considerations
- Timing: The patent was filed around or before 2020, with possible extensions or publications. Its patent term lasts typically 20 years from filing.
- Patent strength: The scope of claims, inventive step over prior art, and any patent challenges influence enforceability.
- Competing portfolios: Companies working on similar indications may have overlapping or blocking patents.
Patent Citations and Litigation
Patent litigation involving HRP20200046 appears limited or not publicly disclosed. The patent literature cites prior art related to the active compound, formulations, or therapeutic methods, which can inform its novelty and inventive step.
Strategic implications
- For licensees or competitors, the narrow territorial scope limits immediate infringing risk outside Croatia unless extensions are pursued.
- The core claims around the active ingredient or method may intersect with filings in other jurisdictions, requiring comprehensive freedom-to-operate analyses.
- The patent’s expiry date is likely around 2040, depending on filing date and patent term adjustments.
Conclusion
Patent HRP20200046 encompasses claims on a pharmaceutical composition/method targeting a medical condition, with a focus on specific formulations or uses. Its legal protection remains confined geographically unless broadened. The patent landscape indicates potential for broader patent family protection, but detailed examination of claims and prior art is essential for full assessment.
Key Takeaways
- HRP20200046 is a Croatian patent centered on a pharmaceutical composition/method.
- The scope includes active compounds, formulations, and therapeutic methods.
- The patent is territorial; global protection requires additional filings.
- The patent family likely extends into other jurisdictions via PCT or national applications.
- Patent strength depends on claim scope, prior art, and enforcement history.
FAQs
1. How do I determine if HRP20200046 covers the same invention as similar patents?
Compare claim language, especially the scope of active compounds, formulations, and therapeutic methods. Use patent databases to identify overlapping claims.
2. Can this patent be challenged or invalidated?
Yes, through invalidation procedures based on prior art, lack of novelty, or obviousness. Conduct a thorough prior art search for technical and legal risks.
3. What is the typical duration of protection for a patent like HRP20200046?
20 years from the earliest filing date, subject to maintenance fees and national law adjustments.
4. Is protection extended to the EU or US through this Croatian patent?
No, Croatia is a member of the European Patent Convention, but this patent does not automatically extend beyond Croatia. Separate filings are needed.
5. What are potential next steps for companies interested in this patent?
Investigate patent family documents to explore broader territorial rights. Assess patent claims thoroughly and consider licensing, designing around, or challenging the patent if necessary.
References
- European Patent Office. (2022). European Patent Register. Retrieved from https://www.epo.org/searching-for-patents/legal/register.html
- World Intellectual Property Organization. (2023). Patent Cooperation Treaty (PCT). Retrieved from https://www.wipo.int/pct/en/
- Croatian Intellectual Property Office. (2023). Patent Data. Retrieved from https://www.dziv.hr/
